ID ACTC_HUMAN Reviewed; 377 AA. AC P68032; P04270; DT 20-MAR-1987, integrated into UniProtKB/Swiss-Prot. DT 20-MAR-1987, sequence version 1. DT 02-SEP-2026, entry version 188. DE RecName: Full=Actin, alpha cardiac muscle 1; DE EC=3.6.4.- {ECO:0000250|UniProtKB:P68137}; DE AltName: Full=Alpha-cardiac actin; DE Contains: DE RecName: Full=Actin, alpha cardiac muscle 1, intermediate form; DE Flags: Precursor; GN Name=ACTC1; Synonyms=ACTC; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=6310553; DOI=10.1073/pnas.79.19.5901; RA Hamada H., Petrino M.G., Kakunaga T.; RT "Molecular structure and evolutionary origin of human cardiac muscle actin RT gene."; RL Proc. Natl. Acad. Sci. U.S.A. 79:5901-5905(1982). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP CROSS-LINK BY V.CHOLERAE TOXIN RTXA (MICROBIAL INFECTION). RX PubMed=19015515; DOI=10.1073/pnas.0808082105; RA Kudryashov D.S., Durer Z.A., Ytterberg A.J., Sawaya M.R., Pashkov I., RA Prochazkova K., Yeates T.O., Loo R.R., Loo J.A., Satchell K.J., Reisler E.; RT "Connecting actin monomers by iso-peptide bond is a toxicity mechanism of RT the Vibrio cholerae MARTX toxin."; RL Proc. Natl. Acad. Sci. U.S.A. 105:18537-18542(2008). RN [5] RP METHYLATION AT LYS-86, AND DEMETHYLATION BY ALKBH4. RX PubMed=23673617; DOI=10.1038/ncomms2863; RA Li M.M., Nilsen A., Shi Y., Fusser M., Ding Y.H., Fu Y., Liu B., Niu Y., RA Wu Y.S., Huang C.M., Olofsson M., Jin K.X., Lv Y., Xu X.Z., He C., RA Dong M.Q., Rendtlew Danielsen J.M., Klungland A., Yang Y.G.; RT "ALKBH4-dependent demethylation of actin regulates actomyosin dynamics."; RL Nat. Commun. 4:1832-1832(2013). RN [6] RP CROSS-LINK BY V.CHOLERAE TOXIN RTXA (MICROBIAL INFECTION). RX PubMed=26228148; DOI=10.1126/science.aab4090; RA Heisler D.B., Kudryashova E., Grinevich D.O., Suarez C., Winkelman J.D., RA Birukov K.G., Kotha S.R., Parinandi N.L., Vavylonis D., Kovar D.R., RA Kudryashov D.S.; RT "ACD toxin-produced actin oligomers poison formin-controlled actin RT polymerization."; RL Science 349:535-539(2015). RN [7] RP METHYLATION AT HIS-75. RX PubMed=30626964; DOI=10.1038/s41586-018-0821-8; RA Wilkinson A.W., Diep J., Dai S., Liu S., Ooi Y.S., Song D., Li T.M., RA Horton J.R., Zhang X., Liu C., Trivedi D.V., Ruppel K.M., RA Vilches-Moure J.G., Casey K.M., Mak J., Cowan T., Elias J.E., RA Nagamine C.M., Spudich J.A., Cheng X., Carette J.E., Gozani O.; RT "SETD3 is an actin histidine methyltransferase that prevents primary RT dystocia."; RL Nature 565:372-376(2019). RN [8] RP VARIANTS CMD1R HIS-314 AND GLY-363. RX PubMed=9563954; DOI=10.1126/science.280.5364.750; RA Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.-S., Keating M.T.; RT "Actin mutations in dilated cardiomyopathy, a heritable form of heart RT failure."; RL Science 280:750-752(1998). RN [9] RP VARIANT CMH11 SER-297. RX PubMed=10330430; DOI=10.1172/jci6460; RA Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T.A., RA Gregersen N., Hansen P.S., Baandrup U., Boerglum A.D.; RT "Alpha-cardiac actin is a novel disease gene in familial hypertrophic RT cardiomyopathy."; RL J. Clin. Invest. 103:R39-R43(1999). RN [10] RP VARIANTS CMH11 LYS-101; ALA-166 AND PRO-333. RX PubMed=10966831; DOI=10.1006/jmcc.2000.1204; RA Olson T.M., Doan T.P., Kishimoto N.Y., Whitby F.G., Ackerman M.J., RA Fananapazir L.; RT "Inherited and de novo mutations in the cardiac actin gene cause RT hypertrophic cardiomyopathy."; RL J. Mol. Cell. Cardiol. 32:1687-1694(2000). RN [11] RP VARIANTS CMH11 CYS-168 AND LEU-307. RX PubMed=14729850; DOI=10.1136/jmg.2003.010447; RA Mogensen J., Perrot A., Andersen P.S., Havndrup O., Klausen I.C., RA Christiansen M., Bross P., Egeblad H., Bundgaard H., Osterziel K.J., RA Haltern G., Lapp H., Reinecke P., Gregersen N., Borglum A.D.; RT "Clinical and genetic characteristics of alpha cardiac actin gene mutations RT in hypertrophic cardiomyopathy."; RL J. Med. Genet. 41:E10-E10(2004). RN [12] RP VARIANT ASD5 VAL-125, AND CHARACTERIZATION OF VARIANT ASD5 VAL-125. RX PubMed=17947298; DOI=10.1093/hmg/ddm302; RA Matsson H., Eason J., Bookwalter C.S., Klar J., Gustavsson P., RA Sunnegardh J., Enell H., Jonzon A., Vikkula M., Gutierrez I., RA Granados-Riveron J., Pope M., Bu'Lock F., Cox J., Robinson T.E., Song F., RA Brook D.J., Marston S., Trybus K.M., Dahl N.; RT "Alpha-cardiac actin mutations produce atrial septal defects."; RL Hum. Mol. Genet. 17:256-265(2008). RN [13] RP VARIANTS CMH11 TYR-90 AND CYS-97. RX PubMed=18403758; DOI=10.1056/nejmoa075463; RA Morita H., Rehm H.L., Menesses A., McDonough B., Roberts A.E., RA Kucherlapati R., Towbin J.A., Seidman J.G., Seidman C.E.; RT "Shared genetic causes of cardiac hypertrophy in children and adults."; RL N. Engl. J. Med. 358:1899-1908(2008). CC -!- FUNCTION: Actins are highly conserved proteins that are involved in CC various types of cell motility and are ubiquitously expressed in all CC eukaryotic cells. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; CC Evidence={ECO:0000250|UniProtKB:P68137}; CC -!- SUBUNIT: Polymerization of globular actin (G-actin) leads to a CC structural filament (F-actin) in the form of a two-stranded helix. Each CC actin can bind to 4 others. CC -!- INTERACTION: CC P68032; P23528: CFL1; NbExp=2; IntAct=EBI-352273, EBI-352733; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. CC -!- PTM: Oxidation of Met-46 and Met-49 by MICALs (MICAL1, MICAL2 or CC MICAL3) to form methionine sulfoxide promotes actin filament CC depolymerization. MICAL1 and MICAL2 produce the (R)-S-oxide form. The CC (R)-S-oxide form is reverted by MSRB1 and MSRB2, which promotes actin CC repolymerization. {ECO:0000250|UniProtKB:P68033}. CC -!- PTM: Monomethylation at Lys-86 (K86me1) regulates actin-myosin CC interaction and actomyosin-dependent processes. Demethylation by ALKBH4 CC is required for maintaining actomyosin dynamics supporting normal CC cleavage furrow ingression during cytokinesis and cell migration. CC {ECO:0000269|PubMed:23673617}. CC -!- PTM: [Actin, alpha cardiac muscle 1, intermediate form]: N-terminal CC cleavage of acetylated cysteine of intermediate muscle actin by ACTMAP. CC {ECO:0000250|UniProtKB:P68033}. CC -!- PTM: Methylated at His-75 by SETD3. {ECO:0000269|PubMed:30626964}. CC -!- PTM: (Microbial infection) Monomeric actin is cross-linked by CC V.cholerae toxins RtxA and VgrG1 in case of infection: bacterial toxins CC mediate the cross-link between Lys-52 of one monomer and Glu-272 of CC another actin monomer, resulting in formation of highly toxic actin CC oligomers that cause cell rounding (PubMed:19015515). The toxin can be CC highly efficient at very low concentrations by acting on formin CC homology family proteins: toxic actin oligomers bind with high affinity CC to formins and adversely affect both nucleation and elongation CC abilities of formins, causing their potent inhibition in both profilin- CC dependent and independent manners (PubMed:26228148). CC {ECO:0000305|PubMed:19015515, ECO:0000305|PubMed:26228148}. CC -!- DISEASE: Cardiomyopathy, dilated, 1R (CMD1R) [MIM:613424]: A disorder CC characterized by ventricular dilation and impaired systolic function, CC resulting in congestive heart failure and arrhythmia. Patients are at CC risk of premature death. {ECO:0000269|PubMed:9563954}. Note=The disease CC is caused by variants affecting the gene represented in this entry. CC -!- DISEASE: Cardiomyopathy, familial hypertrophic, 11 (CMH11) CC [MIM:612098]: A hereditary heart disorder characterized by ventricular CC hypertrophy, which is usually asymmetric and often involves the CC interventricular septum. The symptoms include dyspnea, syncope, CC collapse, palpitations, and chest pain. They can be readily provoked by CC exercise. The disorder has inter- and intrafamilial variability ranging CC from benign to malignant forms with high risk of cardiac failure and CC sudden cardiac death. {ECO:0000269|PubMed:10330430, CC ECO:0000269|PubMed:10966831, ECO:0000269|PubMed:14729850, CC ECO:0000269|PubMed:18403758}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- DISEASE: Atrial septal defect 5 (ASD5) [MIM:612794]: A congenital heart CC malformation characterized by incomplete closure of the wall between CC the atria resulting in blood flow from the left to the right atria. CC {ECO:0000269|PubMed:17947298}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- MISCELLANEOUS: In vertebrates 3 main groups of actin isoforms, alpha, CC beta and gamma have been identified. The alpha actins are found in CC muscle tissues and are a major constituent of the contractile CC apparatus. The beta and gamma actins coexist in most cell types as CC components of the cytoskeleton and as mediators of internal cell CC motility. CC -!- SIMILARITY: Belongs to the actin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J00073; AAB59619.1; -; Genomic_DNA. DR EMBL; J00070; AAB59619.1; JOINED; Genomic_DNA. DR EMBL; J00071; AAB59619.1; JOINED; Genomic_DNA. DR EMBL; J00072; AAB59619.1; JOINED; Genomic_DNA. DR EMBL; CR541795; CAG46594.1; -; mRNA. DR EMBL; BC009978; AAH09978.1; -; mRNA. DR CCDS; CCDS10041.1; -. DR PIR; A02998; ATHUC. DR RefSeq; NP_001393411.1; NM_001406482.1. DR RefSeq; NP_001393412.1; NM_001406483.1. DR RefSeq; NP_005150.1; NM_005159.5. DR RefSeq; XP_047288935.1; XM_047432979.1. DR PDB; 8GSU; X-ray; 1.50 A; A=3-377. DR PDB; 8GSW; X-ray; 1.40 A; A=3-377. DR PDB; 8GT1; X-ray; 1.35 A; A=3-377. DR PDB; 8GT2; X-ray; 1.50 A; A=3-377. DR PDB; 8GT3; X-ray; 1.50 A; A=3-377. DR PDB; 8GT4; X-ray; 1.55 A; A=3-377. DR PDB; 8GT5; X-ray; 1.40 A; A=3-377. DR PDB; 8ZB7; EM; 3.19 A; A/B/C/D/E/F=7-377. DR PDB; 8ZI9; EM; 3.08 A; F=7-377. DR PDB; 8ZJ1; EM; 4.25 A; A/C/D/E/F=7-377. DR PDB; 9B3Q; EM; 3.60 A; A/D/E=1-377. DR PDB; 9B3R; EM; 3.50 A; A/D/E=1-377. DR PDB; 9BPH; EM; 3.12 A; A/B/C/D=3-377. DR PDB; 9BPM; EM; 3.42 A; A/B/C/D=3-377. DR PDB; 9ZBL; EM; 2.79 A; A/B/C/D/E/F=1-377. DR PDB; 9ZBP; EM; 3.12 A; A/B/C/D/E/F=1-377. DR AlphaFoldDB; P68032; -. DR EMDB; EMD-39896; -. DR EMDB; EMD-44153; -. DR EMDB; EMD-44154; -. DR EMDB; EMD-44777; -. DR EMDB; EMD-44781; -. DR EMDB; EMD-60122; -. DR EMDB; EMD-60135; -. DR EMDB; EMD-73993; -. DR EMDB; EMD-73996; -. DR SMR; P68032; -. DR BioGRID; 106585; 700. DR FunCoup; P68032; 966. DR IntAct; P68032; 107. DR MINT; P68032; -. DR NDEx; IQUERY-CP-ACTC1; 4 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000290378; -. DR BindingDB; P68032; -. DR ChEMBL; CHEMBL6066852; -. DR GlyGen; P68032; 3 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (2 sites). DR iPTMnet; P68032; -. DR MetOSite; P68032; -. DR PhosphoSitePlus; P68032; -. DR SwissPalm; P68032; -. DR BioMuta; ACTC1; -. DR DMDM; 54036697; -. DR REPRODUCTION-2DPAGE; P68032; -. DR jPOST; P68032; -. DR MassIVE; P68032; -. DR PaxDb; 9606-ENSP00000290378; -. DR PeptideAtlas; P68032; -. DR PRIDE; P68032; -. DR ProteomicsDB; 57527; -. DR Pumba; P68032; -. DR TopDownProteomics; P68032; -. DR Antibodypedia; 9782; 347 antibodies from 38 providers. DR DNASU; 70; -. DR Ensembl; ENST00000290378.6; ENSP00000290378.4; ENSG00000159251.11. DR Ensembl; ENST00000713610.1; ENSP00000518905.1; ENSG00000159251.11. DR Ensembl; ENST00000713615.1; ENSP00000518911.1; ENSG00000159251.11. DR Ensembl; ENST00000868405.1; ENSP00000538464.1; ENSG00000159251.11. DR Ensembl; ENST00000953688.1; ENSP00000623747.1; ENSG00000159251.11. DR GeneID; 70; -. DR KEGG; hsa:70; -. DR MANE-Select; ENST00000290378.6; ENSP00000290378.4; NM_005159.5; NP_005150.1. DR UCSC; uc001ziu.2; human. DR AGR; HGNC:143; -. DR ClinPGx; PA162375571; -. DR CTD; 70; -. DR DisGeNET; 70; -. DR GeneCards; ACTC1; -. DR GeneReviews; ACTC1; -. DR HGNC; HGNC:143; ACTC1. DR HPA; ENSG00000159251; Tissue enriched (heart). DR MalaCards; ACTC1; -. DR MIM; 102540; gene. DR MIM; 612098; phenotype. DR MIM; 612794; phenotype. DR MIM; 613424; phenotype. DR OpenTargets; ENSG00000159251; -. DR Orphanet; 99103; Atrial septal defect, ostium secundum type. DR Orphanet; 154; Familial isolated dilated cardiomyopathy. DR Orphanet; 54260; Left ventricular noncompaction. DR VEuPathDB; HostDB:ENSG00000159251; -. DR eggNOG; KOG0676; Eukaryota. DR GeneTree; ENSGT00940000154710; -. DR HOGENOM; CLU_027965_0_2_1; -. DR InParanoid; P68032; -. DR OMA; FTTSAEF; -. DR OrthoDB; 9816491at2759; -. DR PAN-GO; P68032; 8 GO annotations based on evolutionary models. DR PhylomeDB; P68032; -. DR PathwayCommons; P68032; -. DR Reactome; R-HSA-390522; Striated Muscle Contraction. DR Reactome; R-HSA-8980692; RHOA GTPase cycle. DR Reactome; R-HSA-9013026; RHOB GTPase cycle. DR Reactome; R-HSA-9764561; Regulation of CDH1 Function. DR Reactome; R-HSA-9913351; Formation of the dystrophin-glycoprotein complex (DGC). DR Reactome; R-HSA-9958825; Activation of STAT3 by cadherin engagement. DR SignaLink; P68032; -. DR SIGNOR; P68032; -. DR Agora; ENSG00000159251; -. DR BioGRID-ORCS; 70; 7 hits in 1146 CRISPR screens. DR CD-CODE; DEE660B4; Stress granule. DR ChiTaRS; ACTC1; human. DR GeneWiki; ACTC1; -. DR GenomeRNAi; 70; -. DR Pharos; P68032; Tbio. DR PRO; PR:P68032; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; P68032; protein. DR Bgee; ENSG00000159251; Expressed in left ventricle myocardium and 156 other cell types or tissues. DR GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central. DR GO; GO:0005884; C:actin filament; IDA:UniProtKB. DR GO; GO:0072562; C:blood microparticle; HDA:UniProtKB. DR GO; GO:0044297; C:cell body; ISS:AgBase. DR GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005576; C:extracellular region; HDA:UniProtKB. DR GO; GO:0030175; C:filopodium; ISS:AgBase. DR GO; GO:0005925; C:focal adhesion; HDA:UniProtKB. DR GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl. DR GO; GO:0031674; C:I band; ISS:UniProtKB. DR GO; GO:0030027; C:lamellipodium; ISS:AgBase. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0030017; C:sarcomere; IDA:UniProtKB. DR GO; GO:0005524; F:ATP binding; IDA:UniProtKB. DR GO; GO:0016887; F:ATP hydrolysis activity; ISS:UniProtKB. DR GO; GO:0000146; F:microfilament motor activity; IDA:UniProtKB. DR GO; GO:0017022; F:myosin binding; IDA:BHF-UCL. DR GO; GO:0005200; F:structural constituent of cytoskeleton; IBA:GO_Central. DR GO; GO:0007015; P:actin filament organization; IBA:GO_Central. DR GO; GO:0030048; P:actin filament-based movement; IDA:UniProtKB. DR GO; GO:0033275; P:actin-myosin filament sliding; IMP:BHF-UCL. DR GO; GO:0031032; P:actomyosin structure organization; ISS:UniProtKB. DR GO; GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:UniProtKB. DR GO; GO:0055003; P:cardiac myofibril assembly; ISS:UniProtKB. DR GO; GO:0060047; P:heart contraction; IMP:UniProtKB. DR GO; GO:0090131; P:mesenchyme migration; ISS:AgBase. DR GO; GO:0010628; P:positive regulation of gene expression; ISS:AgBase. DR GO; GO:0030240; P:skeletal muscle thin filament assembly; ISS:UniProtKB. DR CDD; cd10224; ASKHA_NBD_actin; 1. DR FunFam; 3.30.420.40:FF:000131; Actin, alpha skeletal muscle; 1. DR FunFam; 3.30.420.40:FF:000291; Actin, alpha skeletal muscle; 1. DR FunFam; 3.90.640.10:FF:000047; Actin, alpha skeletal muscle; 1. DR FunFam; 3.30.420.40:FF:000058; Putative actin-related protein 5; 1. DR Gene3D; 3.30.420.40; -; 2. DR Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1. DR InterPro; IPR004000; Actin. DR InterPro; IPR020902; Actin/actin-like_CS. DR InterPro; IPR004001; Actin_CS. DR InterPro; IPR043129; ATPase_NBD. DR PANTHER; PTHR11937; ACTIN; 1. DR Pfam; PF00022; Actin; 1. DR PRINTS; PR00190; ACTIN. DR SMART; SM00268; ACTIN; 1. DR SUPFAM; SSF53067; Actin-like ATPase domain; 2. DR PROSITE; PS00406; ACTINS_1; 1. DR PROSITE; PS00432; ACTINS_2; 1. DR PROSITE; PS01132; ACTINS_ACT_LIKE; 1. DR PDBsum; 8GSU; -. DR PDBsum; 8GSW; -. DR PDBsum; 8GT1; -. DR PDBsum; 8GT2; -. DR PDBsum; 8GT3; -. DR PDBsum; 8GT4; -. DR PDBsum; 8GT5; -. DR PDBsum; 8ZB7; -. DR PDBsum; 8ZI9; -. DR PDBsum; 8ZJ1; -. DR PDBsum; 9B3Q; -. DR PDBsum; 9B3R; -. DR PDBsum; 9BPH; -. DR PDBsum; 9BPM; -. DR PDBsum; 9ZBL; -. DR PDBsum; 9ZBP; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; ATP-binding; Atrial septal defect; KW Cardiomyopathy; Cytoplasm; Cytoskeleton; Disease variant; Hydrolase; KW Isopeptide bond; Methylation; Muscle protein; Nucleotide-binding; KW Oxidation; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT CHAIN 2..377 FT /note="Actin, alpha cardiac muscle 1, intermediate form" FT /evidence="ECO:0000250|UniProtKB:P62737" FT /id="PRO_0000442998" FT CHAIN 3..377 FT /note="Actin, alpha cardiac muscle 1" FT /evidence="ECO:0000250|UniProtKB:P68135" FT /id="PRO_0000000813" FT MOD_RES 2 FT /note="N-acetylcysteine; in intermediate form" FT /evidence="ECO:0000250|UniProtKB:P62737" FT MOD_RES 46 FT /note="Methionine (R)-sulfoxide" FT /evidence="ECO:0000250|UniProtKB:P68033" FT MOD_RES 49 FT /note="Methionine (R)-sulfoxide" FT /evidence="ECO:0000250|UniProtKB:P68033" FT MOD_RES 75 FT /note="Tele-methylhistidine" FT /evidence="ECO:0000269|PubMed:30626964" FT MOD_RES 86 FT /note="N6-methyllysine" FT /evidence="ECO:0000269|PubMed:23673617" FT CROSSLNK 52 FT /note="Isoglutamyl lysine isopeptide (Lys-Glu) (interchain FT with E-272); by Vibrio toxins RtxA and VgrG1" FT /evidence="ECO:0000250|UniProtKB:P60709" FT CROSSLNK 272 FT /note="Isoglutamyl lysine isopeptide (Glu-Lys) (interchain FT with K-52); by Vibrio toxins RtxA and VgrG1" FT /evidence="ECO:0000250|UniProtKB:P60709" FT VARIANT 90 FT /note="H -> Y (in CMH11; dbSNP:rs121912676)" FT /evidence="ECO:0000269|PubMed:18403758" FT /id="VAR_045924" FT VARIANT 97 FT /note="R -> C (in CMH11; dbSNP:rs759495229)" FT /evidence="ECO:0000269|PubMed:18403758" FT /id="VAR_045925" FT VARIANT 101 FT /note="E -> K (in CMH11; dbSNP:rs193922680)" FT /evidence="ECO:0000269|PubMed:10966831" FT /id="VAR_012857" FT VARIANT 125 FT /note="M -> V (in ASD5; reduced affinity for myosin; normal FT actin filament polymerization ability; normal actomyosin FT motor function; dbSNP:rs121912677)" FT /evidence="ECO:0000269|PubMed:17947298" FT /id="VAR_046502" FT VARIANT 166 FT /note="P -> A (in CMH11; dbSNP:rs267606628)" FT /evidence="ECO:0000269|PubMed:10966831" FT /id="VAR_012858" FT VARIANT 168 FT /note="Y -> C (in CMH11; dbSNP:rs2140430974)" FT /evidence="ECO:0000269|PubMed:14729850" FT /id="VAR_046503" FT VARIANT 297 FT /note="A -> S (in CMH11; dbSNP:rs121912675)" FT /evidence="ECO:0000269|PubMed:10330430" FT /id="VAR_012859" FT VARIANT 307 FT /note="M -> L (in CMH11; dbSNP:rs2140429593)" FT /evidence="ECO:0000269|PubMed:14729850" FT /id="VAR_046504" FT VARIANT 314 FT /note="R -> H (in CMD1R; dbSNP:rs121912673)" FT /evidence="ECO:0000269|PubMed:9563954" FT /id="VAR_012860" FT VARIANT 333 FT /note="A -> P (in CMH11; dbSNP:rs267606629)" FT /evidence="ECO:0000269|PubMed:10966831" FT /id="VAR_012861" FT VARIANT 363 FT /note="E -> G (in CMD1R; dbSNP:rs121912674)" FT /evidence="ECO:0000269|PubMed:9563954" FT /id="VAR_012862" FT STRAND 10..14 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 16..23 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 26..28 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 30..34 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 37..41 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 47..49 FT /evidence="ECO:0007829|PDB:8ZI9" FT HELIX 58..62 FT /evidence="ECO:0007829|PDB:8GT1" FT TURN 63..65 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 66..70 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 72..74 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 81..89 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 90..96 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 100..102 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 105..109 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 115..127 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 132..138 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 139..146 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 150..157 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 162..168 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 174..176 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 178..181 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 184..195 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 196..198 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 205..218 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 225..234 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 240..243 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 249..253 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 255..264 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 266..269 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 273..275 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 276..285 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 289..296 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 299..303 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 304..307 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 311..322 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 337..339 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 340..348 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 352..356 FT /evidence="ECO:0007829|PDB:8GT1" FT STRAND 358..360 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 361..367 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 369..371 FT /evidence="ECO:0007829|PDB:8GT1" FT HELIX 372..375 FT /evidence="ECO:0007829|PDB:8GT1" SQ SEQUENCE 377 AA; 42019 MW; E5C10FA19730CAD2 CRC64; MCDDEETTAL VCDNGSGLVK AGFAGDDAPR AVFPSIVGRP RHQGVMVGMG QKDSYVGDEA QSKRGILTLK YPIEHGIITN WDDMEKIWHH TFYNELRVAP EEHPTLLTEA PLNPKANREK MTQIMFETFN VPAMYVAIQA VLSLYASGRT TGIVLDSGDG VTHNVPIYEG YALPHAIMRL DLAGRDLTDY LMKILTERGY SFVTTAEREI VRDIKEKLCY VALDFENEMA TAASSSSLEK SYELPDGQVI TIGNERFRCP ETLFQPSFIG MESAGIHETT YNSIMKCDID IRKDLYANNV LSGGTTMYPG IADRMQKEIT ALAPSTMKIK IIAPPERKYS VWIGGSILAS LSTFQQMWIS KQEYDEAGPS IVHRKCF //